News
Researchers develop blood-brain-barrier-permeable nanoparticles for Alzheimer's disease treatment [23-08-2022]
Alzheimer´s disease (AD) is a complex neurodegenerative disease that leads to insidious deterioration of brain functions. Current treatments for AD that focus on inhibition of amyloid beta (Aβ) aggregation failed to show effectiveness in people with AD symptoms.
Related News
ICN2 Spin-off INBRAIN Neuroelectronics Achieves the World´s First Application of a Graphene Brain-Computer Interface in a Human Patient [27-09-2024]
Nanomedicine, Graphene
A nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment [01-02-2024]
Nanomedicine
Metal-free graphene quantum dots show promise for highly efficient tumor therapy [12-01-2024]
Nanomedicine, Graphene, Quantum Science
Using AI, researchers identify a new class of antibiotic candidates that can kill a drug-resistant bacterium [20-12-2023]
Nanobiotechnology, Nanomedicine, Artificial intelligence
Researchers propose new strategy to improve efficiency for nanotherapeutic delivery in tumors [23-10-2023]
Nanomedicine
CLOSE
Sitemap
  NEWS
  CONFERENCES
  JOBS
  PH REPORTS

© Phantoms Foundation 2024